Caricamento...
LGG-15. CARBOPLATIN IS SYNERGISTIC WITH MAPK INHIBITORS TRAMETINIB AND EVEROLIMUS IN LOW GRADE GLIOMA MODELS
Pediatric lower grade glioma (LGG) can cause significant morbidity and mortality in patients. Tumors often initially respond to first line chemotherapies, such as carboplatin, but approximately 50% of the time tumors recur and require additional therapy. The discovery that aggressive LGG often have...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475104/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.148 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|